Femara® helps protect against return of breast cancer
- Details
- Category: Novartis
![Novartis AG Novartis AG](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Nycomed intends to move chemical production to Indian joint venture
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Baxter and its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs
- Details
- Category: Business
Baxter International Inc. and The Baxter International Foundation, the philanthropic arm of Baxter, today announced their combined 2007 charitable giving, which focused on increasing access to healthcare, helping developing nations and countries in crisis, and addressing other critical community needs.
A successful 2007 paves the way for future of Nycomed
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
- Details
- Category: Amgen
Amgen Inc. (NASDAQ:AMGN) announced the U.S. Food and Drug Administration (FDA) has approved updated safety information, including an updated boxed warning in the labeling information for the class of drugs known as erythropoiesis-stimulating agents (ESAs), including Aranesp(R) (darbepoetin alfa) and EPOGEN(R) (Epoetin alfa).
Pfizer Wins Challenge to Two Main U.S. Patents for Celebrex
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
DAIICHI SANKYO acquires osteoporosis medication EVISTA® from Lilly
- Details
- Category: Daiichi Sankyo
![DAIICHI SANKYO Company DAIICHI SANKYO Company](http://www.worldpharmanews.com/images/stories/logo/daiichi-sankyo.gif)
More Pharma News ...
- Genzyme Launches Renvela® in the U.S. for Dialysis Patients
- Pfizer Presents New Opportunities for Global Growth
- FDA grants Priority Review For Promacta/Revolade (Eltrombopag)
- Court decides against Bayer's Yasmin® patent
- Pfizer to Acquire Serenex to Extend Oncology Pipeline
- Update on GSK's malaria treatments: Dacart and Lapdap
- Johnson & Johnson Diabetes Institute To Provide Education, Training to Health Professionals